These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14598090)

  • 1. Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment.
    Priano L; Albani G; Brioschi A; Guastamacchia G; Calderoni S; Lopiano L; Rizzone M; Cavalli R; Gasco MR; Fraschini F; Bergamasco B; Mauro A
    Neurol Sci; 2003 Oct; 24(3):207-8. PubMed ID: 14598090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal apomorphine permeation from microemulsions: a new treatment in Parkinson's disease.
    Priano L; Albani G; Brioschi A; Calderoni S; Lopiano L; Rizzone M; Cavalli R; Gasco MR; Scaglione F; Fraschini F; Bergamasco B; Mauro A
    Mov Disord; 2004 Aug; 19(8):937-42. PubMed ID: 15300660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled-release transdermal apomorphine treatment for motor fluctuations in Parkinson's disease.
    Priano L; Albani G; Calderoni S; Baudo S; Lopiano L; Rizzone M; Astolfi V; Cavalli R; Gasco MR; Fraschini F; Bergamasco B; Mauro A
    Neurol Sci; 2002 Sep; 23 Suppl 2():S99-100. PubMed ID: 12548362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome.
    Reuter I; Ellis CM; Ray Chaudhuri K
    Acta Neurol Scand; 1999 Sep; 100(3):163-7. PubMed ID: 10478579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease.
    Nomura T; Inoue Y; Mitani H; Kawahara R; Miyake M; Nakashima K
    Mov Disord; 2003 Jul; 18(7):812-7. PubMed ID: 12815661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selected sleep disorders: restless legs syndrome and periodic limb movement disorder, sleep apnea syndrome, and narcolepsy.
    Erman MK
    Psychiatr Clin North Am; 2006 Dec; 29(4):947-67; abstract viii-ix. PubMed ID: 17118276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Night-to-night variability in periodic leg movements in patients with restless legs syndrome.
    Sforza E; Haba-Rubio J
    Sleep Med; 2005 May; 6(3):259-67. PubMed ID: 15854857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges.
    Katzenschlager R; Hughes A; Evans A; Manson AJ; Hoffman M; Swinn L; Watt H; Bhatia K; Quinn N; Lees AJ
    Mov Disord; 2005 Feb; 20(2):151-7. PubMed ID: 15390035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained-release levodopa in parkinsonian patients with nocturnal disabilities.
    Van den Kerchove M; Jacquy J; Gonce M; De Deyn PP
    Acta Neurol Belg; 1993; 93(1):32-9. PubMed ID: 8451915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
    Chen JJ; Obering C
    Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of apomorphine in Parkinson's disease.
    Stocchi F
    Neurol Sci; 2008 Dec; 29 Suppl 5():S383-6. PubMed ID: 19381769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian variation in neuroendocrine response to L-dopa in patients with restless legs syndrome.
    Garcia-Borreguero D; Larrosa O; Granizo JJ; de la Llave Y; Hening WA
    Sleep; 2004 Jun; 27(4):669-73. PubMed ID: 15283001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future delivery systems for apomorphine in patients with Parkinson's disease.
    van Laar T; Van der Geest R; Danhof M
    Adv Neurol; 1999; 80():535-44. PubMed ID: 10410768
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of a mandibular repositioning appliance on sleep structure, morning behavior and clinical symptomatology in patients with snoring and sleep-disordered breathing.
    Saletu A; Anderer P; Parapatics S; Matthai C; Matejka M; Saletu B
    Neuropsychobiology; 2007; 55(3-4):184-93. PubMed ID: 17700043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of normal motor control in Parkinson's disease during REM sleep.
    De Cock VC; Vidailhet M; Leu S; Texeira A; Apartis E; Elbaz A; Roze E; Willer JC; Derenne JP; Agid Y; Arnulf I
    Brain; 2007 Feb; 130(Pt 2):450-6. PubMed ID: 17235126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa in the treatment of Parkinson's disease: current controversies.
    Gerlach M; Reichmann H; Riederer P
    Mov Disord; 2005 May; 20(5):643; author reply 643-4. PubMed ID: 15732130
    [No Abstract]   [Full Text] [Related]  

  • 17. Restless legs syndrome in Parkinson's disease.
    Gómez-Esteban JC; Zarranz JJ; Tijero B; Velasco F; Barcena J; Rouco I; Lezcano E; Lachen MC; Jauregui A; Ugarte A
    Mov Disord; 2007 Oct; 22(13):1912-6. PubMed ID: 17579369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography.
    Dhawan V; Dhoat S; Williams AJ; Dimarco A; Pal S; Forbes A; Tobías A; Martinez-Martin P; Chaudhuri KR
    J Neurol Sci; 2006 Oct; 248(1-2):158-62. PubMed ID: 16780888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodic leg movements during sleep and periodic limb movement disorder in patients presenting with unexplained insomnia.
    Ferri R; Gschliesser V; Frauscher B; Poewe W; Högl B
    Clin Neurophysiol; 2009 Feb; 120(2):257-63. PubMed ID: 19109055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on apomorphine for the rapid treatment of hypomobility ("off") episodes in Parkinson's disease.
    Obering CD; Chen JJ; Swope DM
    Pharmacotherapy; 2006 Jun; 26(6):840-52. PubMed ID: 16716137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.